- £194.74bn
- £213.97bn
- $54.07bn
- 85
- 16
- 87
- 72
REG - AstraZeneca PLC - US FDA Approves Tezspire in CRSwNP
AnnouncementREG - AstraZeneca PLC - Positive CHMP opinion for subcutaneous Saphnelo
AnnouncementREG - AstraZeneca PLC - Agreement with US Govt to lower medicine prices
AnnouncementRCS - LHH - LHH, EZRA's AI Leadership Transformation Program
AnnouncementREG - AstraZeneca PLC - Baxdrostat met primary endpoint in Bax24 Ph3 trial
AnnouncementREG - AstraZeneca PLC - Datroway improved OS and PFS in TROPION-Breast02
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Enhertu improved IDFS in early BC in DB-05
AnnouncementREG - AstraZeneca PLC - AZN harmonises listing structure
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementRCS - Redx Pharma Limited - Redx Pharma to present new Phase 2a data at ERS
AnnouncementREG - AstraZeneca PLC - Koselugo recommended for EU approval
AnnouncementREG - AstraZeneca PLC - Tezspire Recommended for Approval in EU for CRSwNP
AnnouncementREG - AstraZeneca PLC - Saphnelo met primary endpoint in TULIP-SC
AnnouncementREG - AstraZeneca PLC - Update on RESOLUTE Phase III trial
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Holding(s) in Company
AnnouncementREG - AstraZeneca PLC - Holding(s) in Company
AnnouncementREG - AstraZeneca PLC - Holding(s) in Company
Announcement